Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US

PHASE4CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

latanoprost 0.005% ophthalmic solution

One drop in the evening in the affected eye(s) at 8:00pm

DRUG

Travoprost 004% sterile ophthalmic solution

One drop in the evening in the affected eye(s) at 8:00pm

DRUG

Bimatoprost .03% sterile ophthalmic solution

One drop in the evening in the affected eye(s) at 8:00pm

Trial Locations (40)

15224

Pfizer Investigational Site, Pittsburgh

23456

Pfizer Investigational Site, Virginia Beach

23505

Pfizer Investigational Site, Norfolk

23507

Pfizer Investigational Site, Norfolk

27103

Pfizer Investigational Site, Winston-Salem

28210

Pfizer Investigational Site, Charlotte

29412

Pfizer Investigational Site, Charleston

29414

Pfizer Investigational Site, Charleston

29425

Pfizer Investigational Site, Charleston

30339

Pfizer Investigational Site, Atlanta

32174

Pfizer Investigational Site, Ormond Beach

32610

Pfizer Investigational Site, Gainesville

33805

Pfizer Investigational Site, Lakeland

37803

Pfizer Investigational Site, Maryville

38119

Pfizer Investigational Site, Memphis

40207

Pfizer Investigational Site, Louisville

40217

Pfizer Investigational Site, Louisville

44241

Pfizer Investigational Site, Streetsboro

47710

Pfizer Investigational Site, Evansville

60108

Pfizer Investigational Site, Bloomingdale

64111

Pfizer Investigational Site, Kansas City

64114

Pfizer Investigational Site, Kansas City

73104

Pfizer Investigational Site, Oklahoma City

74104

Pfizer Investigational Site, Tulsa

75231

Pfizer Investigational Site, Dallas

77025

Pfizer Investigational Site, Houston

79902

Pfizer Investigational Site, El Paso

84041

Pfizer Investigational Site, Layton

89104

Pfizer Investigational Site, Las Vegas

90301

Pfizer Investigational Site, Inglewood

90706

Pfizer Investigational Site, Bellflower

92103

Pfizer Investigational Site, San Diego

92116

Pfizer Investigational Site, San Diego

94115

Pfizer Investigational Site, San Francisco

98801

Pfizer Investigational Site, Wenatchee

771104

Pfizer Investigational Site, Shreveport

04401

Pfizer Investigational Site, Bangor

68198-5540

Pfizer Investigational Site, Omaha

07003

Pfizer Investigational Site, Bloomfield

08046

Pfizer Investigational Site, Willingboro

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00847483 - Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US | Biotech Hunter | Biotech Hunter